Strategic partnerships Position SCDAA as a collaborative partner for medical researchers, pharmaceutical trials, and health organizations. Leverage current collaborations with NHLBI, NIH, Fulcrum Therapeutics, and TrialX to propose joint initiatives, data sharing, and access to patient networks for trial recruitment, awareness campaigns, and educational programs.

Grant and funding leverage SCDAA operates with substantial funding in the multi‑million range and has a track record of transparency awards. Use this to present premium sponsorship opportunities, donor impact reporting services, and advanced fundraising platforms tailored to large‑scale non‑profit campaigns and capital projects.

Technology enablement The existing tech stack and digital presence indicate readiness to scale digital engagement. Propose enhanced CRM, event management, donor analytics, and targeted communications solutions to improve membership growth, event attendance, and volunteer mobilization for national campaigns.

Policy and advocacy leverage As a national advocacy group with high visibility and board activity, SCDAA is well positioned for policy briefings, patient education programs, and congestion-free oversight reporting. Offer policy analytics, stakeholder engagement platforms, and coalition‑building services to amplify impact and grant eligibility.

Healthcare access focus Recent partnerships aim to improve emergency department access and clinical trial connectivity. Present solutions around patient navigation tools, health information accessibility, caregiver support resources, and clinical trial matchmaking to deepen service delivery and attract sponsorship from health tech and pharma players.